麻酔および呼吸機器市場：現状分析と予測（2021年～2027年）

麻酔および呼吸機器の市場規模は、予測期間（2021年～2027年）に7％の著しいCAGRで拡大すると予測されています。同市場の成長は、主にCOPD、OSAなどの呼吸器疾患の増加、麻酔および呼吸機器の管理のための認識プログラムの急増、高齢者人口の増加により促進されています。

目次

第1章 市場のイントロダクション

第2章 調査手法または仮定

第3章 市場の要約

第4章 エグゼクティブサマリー

第5章麻酔および呼吸機器市場に対するCOVID-19の影響

第6章麻酔および呼吸機器市場の収益、2019年～2027年

第7章 製品タイプ別の市場洞察

• 麻酔装置
  • 麻酔器
  • 麻酔モニター
  • 麻酔情報管理システム
  • その他
• 呼吸装置
  • 呼吸機器
  • 呼吸器用ディスポーザブル
  • 呼吸測定装置
  • その他

第8章 エンドユーザー別の市場洞察

• 病院
• クリニック
• 在宅医療施設
• 外来手術センター

第9章 地域別の市場洞察

• 北米
• 欧州
• アジア太平洋
• その他の地域

第10章麻酔および呼吸機器市場の市場力学

• 市場の促進要因
• 市場の課題
• 影響分析

第11章麻酔および呼吸機器市場の機会

第12章麻酔および呼吸機器市場動向

第13章 法規制の枠組み

第14章 需要側と供給側の分析

• 需要側分析
• 供給側分析

第15章 競合シナリオ

• 競合情勢
  • 企業シェア、収益別

第16章 企業概要

• SunMed
• Smiths Group plc
• ResMed
• Masimo
• Koninklijke Philips N.V.
• Invacare Corporation
• Teleflex Incorporated
• Hamilton Medical
• GE Healthcare
• Fisher & Paykel Healthcare Limited

第17章 免責事項

Anesthesia and Respiratory Devices Market is anticipated display significant CAGR of 7% over the forecast period (2021-2027). The growth of the global anesthesia and respiratory devices market can be mainly attributed due to the rise in respiratory illnesses such as COPD, and OSA coupled with the surge in awareness programs for anesthesia and respiratory devices & management and the increasing geriatric population, thus contributing significantly to the growth of the market. According to the World Health Organization (WHO), every year about 65 million people suffer from COPD, 334 million people suffer from asthma and over 10 million people develop tuberculosis (TB) globally. Furthermore, the rising number of tobacco smokers will upsurge anesthesia and respiratory devices market size over the forecast timeframe. Smoking causes about 90% of all lung cancer deaths and thus smokers are more likely to die from COPD than non-smokers.

Some of the major players operating in the market include SunMed, Smiths Group plc, ResMed, Masimo, Koninklijke Philips N.V., Invacare Corporation, Teleflex Incorporated, Hamilton Medical, GE Healthcare, Fisher & Paykel Healthcare Limited.

The ongoing COVID-19 pandemic across the world have had a tremendous impact on different spectra of society, the market for anesthesia and respiratory devices is no less impacted by this. In the early phase of the pandemic, due to the increasing cases of COVID-19, all hospitals, globally, had canceled their scheduled and elective surgeries. Acute surgical emergencies were still inevitable and were being addressed in a timely and sensible manner. According to the report published by the British Journal of Surgery, in May 2020, an estimated 585,000 elective surgeries were postponed in the 12-week lockdown in India alone, and 28.4 million elective surgeries worldwide are expected to be canceled or postponed. Thus, the halt of surgical procedures is the major factor that is likely to hamper the usage of anesthesia and respiratory devices.

Insights Presented in the Report

"Amongst Product Type, Respiratory Devices segment dominated the market in 2020"

Based on product type, the market is bifurcated into anesthesia devices and respiratory devices. Amongst them, anesthesia devices is further categorized into anesthesia machines, monitors, and anesthetic information management systems. In addition, respiratory devices is further bifurcated into respiratory equipment, respiratory disposables, and respiratory measurement devices. Technological advancements in respiratory devices further offer segment growth opportunities. Additionally, the rising geriatric population that is prone to various respiratory conditions, increasing healthcare expenditure, and emerging market economies will offer growth potential for respiratory devices in the forthcoming period.

"Amongst End User, Diagnostic Centers category to witness fastest growth rate"

Based on end user, the market is bifurcated into hospitals, clinics, homecare settings, ambulatory surgical centers, and others. Among them, the hospital segment held the largest market share in 2020 and is further projected to maintain its leading position in the market during the forecast period. This is mainly due to the rising adoption of anesthesia and respiratory devices in healthcare settings coupled with growing investments by government and private healthcare facilities to update infrastructure and devices. Due to rising chronic diseases, healthcare facilities focus on providing better diagnoses and treatment of these diseases. As per the Pan American Health Organization, 75% of all hospitalized patients require supplemental oxygen treatment. Furthermore, the high demand for therapeutic devices for homecare settings and the launch of homecare devices by key players is also expected to provide lucrative growth opportunities for the market. For instance, In January 2019, Masimo received the FDA approval for MightSat Rx finger pulse oximeter that can be used at home. According to the Agency for Healthcare Research and Quality (AHRQ), in 2014, 17.2 million hospital visits resulted into at least one surgery.

"North America will Dominate the Market During the Forecast Period"

For a better understanding of the demand of Anesthesia and Respiratory Devices Market, the market is analyzed for major regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific); and Rest of World. Currently, North America dominated the market in 2020. In North America, the enlarged availability of anesthesia and respiratory devices in hospitals coupled with an increased incidence of respiratory disorders and lifestyle-related diseases, are driving this market's development in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), about 40 million adults in the U.S., and about 4.7 million middle and early adolescence age individuals smoke at least one tobacco product every day, including e-cigarettes. Thus, the rising geriatric population, chronic diseases, and the number of surgeries with higher adoption and wide accessibility of advanced anesthesia and respiratory devices in the region is expected to drive the North American anesthesia and respiratory devices market.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The Anesthesia and Respiratory Devices Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1.  MARKET INTRODUCTION

• 1.1.    Market Definitions
• 1.2.    Limitation
• 1.3.    Stakeholders
• 1.4.    Currency used in Report

2.  RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Anesthesia and Respiratory Devices Market
• 2.2. Research Methodology of the Anesthesia and Respiratory Devices Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Anesthesia and Respiratory Devices Market Study

3.   MARKET SYNOPSIS

4.    EXECUTIVE SUMMARY

5.    ANESTHESIA AND RESPIRATORY DEVICES MARKET COVID-19 IMPACT

6.    ANESTHESIA AND RESPIRATORY DEVICES MARKET REVENUE, 2019-2027F

7.   MARKET INSIGHTS BY Product Type

• 7.1. Anesthesia Devices
  • 7.1.1. Anesthesia Machines
  • 7.1.2. Anesthesia Monitors
  • 7.1.3. Anesthetic Information Management Systems
  • 7.1.4. Others
• 7.2. Respiratory Devices
  • 7.2.1. Respiratory Equipment
  • 7.2.2. Respiratory Disposables
  • 7.2.3. Respiratory Measurement Devices
  • 7.2.4. Others

8.   MARKET INSIGHTS BY End User

• 8.1. Hospitals
• 8.2.   Clinics
• 8.3.  Homecare Settings
• 8.4.    Ambulatory Surgical Centers

9.   MARKET INSIGHTS BY REGION

• 9.1. North America
  • 9.1.1.                      US US
  • 9.1.2.                      Canada Canada
  • 9.1.3.                      Rest of North America Rest of North America
• 9.2.  Europe
  • 9.2.1.                      Germany Germany
  • 9.2.2.                      Germany UK
  • 9.2.3.                      Germany France
  • 9.2.4.                      Germany Italy
  • 9.2.5.                      Germany Spain
  • 9.2.6.                      Germany Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1.  China
  • 9.3.2.  Japan
  • 9.3.3.   India
  • 9.3.4. Australia
  • 9.3.5.  Rest of Asia-Pacific
• 11.4.               Rest of World 9.4.  Rest of World

10 ANESTHESIA AND RESPIRATORY DEVICES MARKET DYNAMICS

• 12.1.               Market Drivers 10.1.  Market Drivers
• 12.2.               Market Challenges 10.2.  Market Challenges
• 12.3.               Impact Analysis 10.3.   Impact Analysis

11 ANESTHESIA AND RESPIRATORY DEVICES MARKET OPPORTUNITIES

12.  ANESTHESIA AND RESPIRATORY DEVICES MARKET TRENDS

13.   LEGAL & REGULATORY FRAMEWORK

14.   DEMAND AND SUPPLY SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis
  • 14.2.1.  Top Product Launches
  • 14.2.2.  Top Business Partnerships
  • 14.2.3.    Top Business Expansions
  • 14.2.4.  Top Merger and Acquisitions

15.  COMPETITIVE SCENARIO

• 15.1. Competitive Landscape
  • 15.1.1.                  Company Shares, By Revenue

16.   COMPANY PROFILED COMPANY PROFILED

• 16.1.  SunMed
• 16.2. Smiths Group plc
• 16.3. ResMed
• 16.4.  Masimo
• 16.5. Koninklijke Philips N.V.
• 16.6. Invacare Corporation
• 16.7. Teleflex Incorporated
• 16.8. Hamilton Medical
• 16.9. GE Healthcare
• 16.10. Fisher & Paykel Healthcare Limited

17.   DISCLAIMER